SCHEMBL28038290

SCHEMBL28038290

CCN1CCN(c2nc(NCc3ccc(-c4ccccc4NS(C)(=O)=O)nc3)c3ncn(C4CCCC4)c3n2)CC1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 14/20 0.50
CCNE1 P24864 10/20 0.50
CDK2 P24941 10/20 0.50
CDK5 Q00535 3/20 0.50
CDK7 P50613 3/20 0.50
CCNT1 O60563 1/20 0.50
CDK9 P50750 1/20 0.50
CCNH P51946 1/20 0.50
MNAT1 P51948 1/20 0.50
CDK5R1 Q15078 1/20 0.50
CSNK1E P49674 2/20 0.44
CLK1 P49759 2/20 0.44
CLK2 P49760 2/20 0.44
DYRK1A Q13627 2/20 0.44
CLK4 Q9HAZ1 2/20 0.44
FLT3 P36888 2/20 0.43
CTSL P07711 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28037889 0.92 CDK7 (0.54) CDK1CCNE1CDK2CDK5CDK7
SCHEMBL28038243 0.91 CDK1 (0.51) CDK1CCNE1CDK2CDK5CDK7
SCHEMBL28037850 0.88 CDK1 (0.63) CDK1CCNE1CDK2CDK5CDK7
SCHEMBL15941061 0.81 CDK1 (0.65) CDK1CCNE1CDK2CDK5CDK7
SCHEMBL15941040 0.80 CDK1 (0.62) CDK1CCNE1CDK2CDK5CDK7
SCHEMBL28823309 0.80 CDK1 (0.64) CDK1CCNE1CDK2CDK5CDK7
SCHEMBL15940773 0.80 CDK1 (0.66) CDK1CCNE1CDK2CDK5CDK7
SCHEMBL28037848 0.79 CDK1 (0.62) CDK1CCNE1CDK2CDK5CDK7
SCHEMBL28037875 0.79 CDK1 (0.63) CDK1CCNE1CDK2CDK5CDK7
SCHEMBL15941215 0.79 CDK1 (0.63) CDK1CCNE1CDK2CDK5CDK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105026396-A 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions UNIV PALACKEHO 2015-11-04 CN disclosed